Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer

OBJECTIVES: Recent clinical studies have demonstrated that immunotherapy-based neoadjuvant therapy have promising effectiveness for patients with resectable non-small cell lung cancer (NSCLC) in terms of pathologic response. Therefore, we performed this study to investigate whether immunotherapy-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jie, Gu, Linping, Qi, Yuwen, Yao, Yaxian, Lu, Shun, Chen, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560710/
https://www.ncbi.nlm.nih.gov/pubmed/37818382
http://dx.doi.org/10.3389/fimmu.2023.1268251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560710/
https://www.ncbi.nlm.nih.gov/pubmed/37818382
http://dx.doi.org/10.3389/fimmu.2023.1268251

Ejemplares similares